1 / 31

Spirochetales Genus : TREPONEMA, BORRELIA, LEPTOSPIRA,

Lectures mycoplasma,ureaplasma spirochetes-borrelia, leptospira,treponema chlamydia, rickettsia Mycobacterium att. Spirochetales Genus : TREPONEMA, BORRELIA, LEPTOSPIRA,

zorion
Télécharger la présentation

Spirochetales Genus : TREPONEMA, BORRELIA, LEPTOSPIRA,

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Lectures mycoplasma,ureaplasma spirochetes-borrelia, leptospira,treponemachlamydia, rickettsiaMycobacterium att

  2. Spirochetales Genus : TREPONEMA, BORRELIA, LEPTOSPIRA, Species: Treponema pallidum – spp.pallidum - syfilis, -ssp.pertenue, ssp.endemicum Treponema carateum – pinta Borrelia recurrentis – epidemic reccurent fever Borrelia species. – endemic recurent fever Borrelia burgdorferi – borreliosis Leptospira interrogans, L. icterohemorhagicus ...... – leptospirosis Common properties – helikcal gram negative, not cultivable

  3. Treponema T. pallidum (3 subspecies) T. carateum Morphologically identical common serological respond in man – (VDRL, FTA), PNC susceptibility Different epidemiology and clinical signs T.pallidum ssp.pallidum – veneric disease syfilis T.pallidum ssp.endemicus – bejel, T.pallidum ssp. pertenue – framboisie, T.carateum – pinta Physiology and structure - Tr.pallidum „ Spirochete “ = curled hair, strictly human pathogen not cultivable Slow replication (time of replication = 30 hrs) Too thin to be visible in light microscope ( darkfield, fluorescence) non veneric

  4. Patogenesis and immunity OMP – outer membrane protein – adherence, hyaluronidase – only virulent – perivascular infiltration. Host cells are covered. fibronectín – produced by T.p. – anti phagocytal properties Immune answer of patient = tissue destructure Clinics – 3 phases 1) skin in the place of penetration – ulcus durum – primary site of replication (multiple T.sp in ulcus ) endarteritis a periarteritis, infiltration of ulcer with PMNL and makrophages, fagocytosis – spirochets are able to survive it 2) disseminated disease – generalised skin lesions multiple T.sp in blood 3) Plate manifestation in any organ or tissue Spontanneous remmission possible

  5. Laboratory dg Microscopy – early dg - in darkfield in the 1st., 2nd., stadium and congenital syfilis – not appropriate for oral lesion – not pathogenic spirochetes - fluorescence, - impregnation with silver Cultivation – not cultivable on artificial media Serological diagnosis – not treponemal tests – IgG or IgM antibodies cross reactivity with antibodies against lipid ( antigen ) from destructed cells cardiolipín - VDRL, RRR test – floculation of cardiolopin antigen with patien sera with antitreponemal antibodies, VDRL j the only appropriate test for CSF testing and for control of efficiency of therapy - treponemal tests – specific, confirmation FTA-ABS fluorescence absorption test, TPHA – treponema pallidum hemagglutination test

  6. Laboratory dg Microscopy – early dg - in darkfield in the 1st., 2nd., stadium and congenital syfilis – not appropriate for oral lesion – not pathogenic spirochetes - fluorescence, - impregnation with silver Cultivation – not cultivable on artificial media Serological diagnosis – not treponemal tests – IgG or IgM antibodies cross reactivity with antibodies against lipid ( antigen ) from destructed cells cardiolipín - VDRL, RRR test – floculation of cardiolopin antigen with patien sera with antitreponemal antibodies, VDRL j the only appropriate test for CSF testing and for control of efficiency of therapy - treponemal tests – specific, confirmation FTA-ABS fluorescence absorption test, TPHA – treponema pallidum hemagglutination test

  7. False positive Not treponemal – viral infections, colagenosis of vascular system, gravidity, recent immunisation, IM,application of feroin, lepra, malaria Treponemal – pyodermia, skin neoplasma, akne, mycosis, ulcus cruris, reumatoid arthritis, psoriasis, SLE, gravidity, herpes genitalis, autoimmune diseases Sensitivity of test in non treated syphilis primary secundary latent late VDRL 59-87% 100% 73-91% 39-94% FTA 86-100 99-100 96-99 96-100 TPHA 64-87 99-100 96-100 94-100% Interpretation of serological testsNontreponemal tests positive later in the 1 st stadium ,present during not treated lues during the 2nd stadium, 25% of not treated are negat. in the 3rd st.., appropriate for therapy control Treponemal tests less influenced by therapy, specificity 98% Positive in newbornes of inficated mothers ? Congenital syphilis or passive transfer of maternal antibodies

  8. Therapy PNC (!Herxheimer reaction! , V PNC for later stadia G PNC for congenital and late, TTC, ERY, CMP – in the case of allergy, for neurosyphilis only PNC or CMP Prevention and control vaccin not available, therapy of sexual partners, promiscuity a iv drug abusers, AIDS Epidemiology world wiede spread - direct contact - congenital - transfussion of blood Infectivity – low (30%), Infection of fetus soon after infection of mother-bacteraemia in early stages – not treated mother – spontanneous repeated bacteraemias 8 years

  9. Other treponematoses T.pallidum ssp.endemicum – bejel, endemic syphilis, interhuman transmission, nonveneric disease 3 stages: inicial oral lesions, sec. oral defects late gumatas T.pertenue – framboisie (yaws) – granulomatouse disease direct contact with ill skin eatly stage – skin late stage– destruction od skin, lymphatic nodes and bones T. carateum – pinta – primary skin Small papuls, spreading, persisting for years reccurent, disseminating hypopigmentation Therapy: PNC, TTC, CMP Dg: clinical, Mi from lesions, VDRL

  10. Geografical spread of bejel (blue), framboisie (red) a pinta (yellow

  11. Borrelia B.recurrentis- Reccurent fever– epidemic - endemic B.burgdorferi – Lymes diseases– borreliosis – 1977 typical morphology of spirochetales faible staining (anillin stain), flagella, motile, Not cultivable nutritional requirements, replication time 18 hrs, Lab.diagnostic: *Mi in blood smear(reccurent fever), ...........biopsie of skin (borreliosis) *serologic (borreliosis) – IgM, IgG, CSF – Ab index

  12. Borrelia burgdorferi–Lyme disease – borreliosis 1977 arthriis in children tick borne - Ixodes ricinus... (spring, fall differeent species of borrelia - B. garini... different clinical signs present in skin, isolation in later stages (? symptoms – caused by living borrelia or immunopathological mechanismus?) Clinics: INKT 3-30 days, 1) erytema chronicum migrans +nonspecific signs - 4 weeks 2) late manifestation (80% non treated) *neurological and cardial symptoms *arthralgies a arthritis Dg : Mi – scarecly serolog and clinical (ECM ) Therapy:PNC – longtime, DOXY, AMOX, in combination

  13. Serology – only in positive history and clinicIFT ,ELISA tests – all stages Nontreated: IgM 2-4 weaks after appearence of ECM , (MX 6-8w), longlasting in persistent infection IgG MX after 4-6 months., persistent during late manifestation Radical and eatly threatment: - no IgG formation dg neuroboreliosis – detection of Ab in CSF – antibody index – detection of intrathecal production of IgG ab IgG posit. in CSF can be trasfered pasively from blood via HE barriere, IgM cannot be – pentamer molecules Confirmation – Western blot – detection of antibodies against unique antigens (41 kD – flagellar – IgM., 31kD OspA, 34kD OspB, 60kD – in later stages, IgG DNA amplification PCR

  14. Leptospires L.interrogans ? – 19 serogroups and 172 serotypes (ssp.icterohemorhagica) L.biflexa – 38 serogroups and 65 serotypes Pathogennic for annimals spread by urine, canals – surviving 6weeks 22 serotypes responsible for human diseases (diseases are not serotype specific) Clinics: subclinical disease, fever, systemic disease (Weilova disease) Pathogenesis: Spread via intact mucus and small skin injuries, infection of skin and small vessels and all organs (meningitis, hepatal a renal dysfunction, hemorrhagies) Dg. microscopy, agglutiantion

  15. Clinical picture: M.pneumoniae – infections of respiratory tract, atypical pneumonia M.hominis- pyelonefritis, pelvicitis, post delivery fevers, Ureaplazma – uretritis Diagnosis: microscopy – faintly stainable – no cell wall kultivácia: M. pneumoniae – specific media, ox eyes colonies, medium with glucose – change of color indicator when pH chnged because od metabolism of glc to acid – indication of the growth Ureaplasma – detection by metabolicsm of urea and ATB resistance – rapid test serology : detection of IgM against M. pneumoniae Therapy ERY, TTC – M. pneumoniae M. hominis – resitence for ERY

  16. Mycoplasma 69 serotypes and ureaplasma 3 serotypes Common properties, commonly present in the nature, 3 human pathogens, different clinical entities, ethiopathogenesis not exactly clear Mycoplasma pneumoniae, M. hominis, Ureaplsma urealyticum The smallest bacteria without cell wall living free in nature - PNC resistant, Gram negative, formerly classified as viruses Cultivation - media with sterols, colonies of ox eyes generation time 1-6 hrs, Cross reactitivty ( main Ags are proteins and glycoproteins) extracelular pathogens , respiratory infections in summer and fall(epidemies in 4-8 years cycles, most commonly school age children Transmission - inhalation and sexually

  17. Chlamydiae • Formelly classified as big viruses because of their i.c. parasitism, they have special growth cycle, do not have peptidoglycan in the cell wall • they have - both DNA and RNA (they are bacteria), - external and internal membrane like G- (LPS), - they are susceptible to some ATB C. trachomatis, C. psittaci, C.pneumoniae Present in 2 morfological formes: - Elementar body- EB – small, infectious, not dividing - Reticular body -RB – bigger noninfectious, dividing, i.c., metabolical activity – energetic parazitism – can synthetise proteins, cannot produce energy

  18. Chlamydiae – growth cycle • Elementar body (EB) is attached on the surface of the target cell by receptors, internalised by phagocytosis. The cell wall of chlamydia does not allew bacteria to unify the phagosome with lysosome – i.c. surviving. EB sa reorganised to reticular body, that can divide by binnary fission – 24 hrs, than reorganised again to EB, the cell crashes and EB are living the cell (48-72hrs after infection)

  19. Chlamydia trachomatis • 3 serovars – trachomatis (12 serotypes), LGV (3 serotypes) and annimal • Trachomatis – A,B,Ba,C – trachom – blindness B, D-K – in women – cervicitis, uretritis, proctitis, conjunctivitic + coomplications – in men uretritis, proctitis, conjunctivitis + complications – in children – conjunctivitis, pneumonia, - infection during delivery – farygeal carriage and presence at GIT • LGV- L1, L2, L3 -Lymfogranuloma venereum + complication • Pathogenesis – enter via minimal injury - direct destruction of epithelial cells + inflammatory reaction. In LGV infection is localised in lymphnodes– abscess, rupture, fissures, fistulas

  20. Clinical presentation,diagnosis, therapy • Trachom – chronical keratoconjunctivitis – strictures, chronical irritation of cornea via the lid that is deformed, panus, blindness – transmission via hands, towel, fleas, carriage in respiratory tract and GIT in children. • Inclussion conjunctivitis- adult - folicular - mucopurulent pus, keratitis, infiltation of cornea – in connection swith earlier genital infection, autoinnoculation • Neonatal conjunctivitis and pneumonia – inoculation at birth during delivery – hyperaemia and copious pus, interstitial pneumonia, rhinitis, not fever, staccato cough • Urogenital infection – sexually transmitted non gonococcal uretritis – mucopurulent discharge, hypertrofic ektopium, in men assymptomatic • Reiter syndrome – uretritis, conjunctivitis, polyartritis, mucockutaneous lessions – younger men – sequaelae of uretritis • Therapy: i.c. – ERY, TTC, AZI

  21. LVG - Chronic sexually transmitted disease, more often in men, primary lession – small no aches discrete. Heeling – headaches, fever, myalgia. Secudarye stadium – inflamtion of lyphnodes – aches, fluctuation, bubo, growing, drenaige via fistules Systemic manifestation – fever, anorexia, meningismus, arthralgia. Chronical LVG – genital ulceration, fistuls, strictures, genital elephantiasi • Laboratory diagnosis – cytologya – Giemsa stainning – cultivation – on tissues – detection of antigen (OMP or LPS) – ! In cells! – sampling of epitelial cells – detection of Nucleic acid -PCR – detection of viable and non viable cells – is not usefull for monitoring the success of therapy – serology – in endemic area – IgG positive IgM in newborne pneumonia

  22. C. psittací, C.pneumoniae • Respiratory infection – transmitted from parrots and spread via RES and blood. Lung infection. Immune response : mostly lymphocytes. – oedema,thickness of alveolar wall, cyanosis, anoxia – involevement of CNS GIT, systemic (rash, carditis, hepatomegalia, keratoconjunctivitis) • Conjunctivitis of children in Thaiwan – pharyngeal carriage – TWAR strains – bronchitis, pneumonia, sínusitis...., atypical pneumonia, • Dg – serological • TH – ERY, TTC

  23. Rickettsiae • Aerobic, i.c. parasits, G-, growinkg only in eucaryotic cells – formerly described as viruses, surviving phagocytosis, spread to cytoplasma whre they divide by binary fission • 4 genuses – Rickettsia, Coxiella ( surviveoutside the cell) Rochalimea – e.c., Ehrlichia ( forms elementary and incitial bodies and morula - all forms are i.c.) • Transmitted by insects – (with exeption of Coxiella)

  24. Rickettsiae • Rickettsia rickettsii –Rocky mountains fever – tickborne – transovarial transmission, reservoir – rodents – spotted fever. Dg – Giemsa staining, tissue clutures - Weil Felixov test – cross reactivity with Proteus sp. antigens. Th: TTC, CMP • Rickettsia prowazekií – spotted fever – human louse vector – man is reservoire ( bad living conditions) . Louse dies for infection – not transovarial transmission transovariálny prenos – epidemic typhus – macular exantem. Reactivation after years Brill Zinser´s disease. • Rickettsia typií – endemic typhus – vector :Xenophylla cheopsis, reservoires -rodent . Maculopalar rash. Not complicated. • Ricketsia Tsutsugamushi – Pacific

  25. Coxiella, Ehrlichia, Rochalimaea • C. burnetti – Q fever – inhalation of infectious partivles from contaminated environment, no insect vector. Proliferation in respiratory tract – dissemination – pneumonia, granulomatous hepatitis. Infection of wild annimals and insect, spred via urine, milk, stool – raw milk,vegetable Acute infection – rapid development, flu disease, respiratory infection, hepatosplenomegalia. Chronic infection – diffuse granulomatosis – chronic endocarditis. Dg – difficult by serology – antigenic variation od phases I and II • Ehrlichia – Paul Ehrlich – leucocytar rickettsiae, parasitism on lymphocytes, neutrophils a monocytes. Not ery. Ehrlichiosis – tick borne – flu signs, leucopenia, trombocytopenia. Rash only in 20%. Good prognosis • R.quintana, R. henselae

  26. Antituberculotics and therapy • Streptomycin(kill actively multiplying M.tbc) Izoniazid,Rifampicin (effective on M.tbc in caseous necrosis) Ethanbutol Etionamid Kanamycin Cycloserin Pyrazinamid ( active i.c.) • In pacient with pulmonar tbc - 3 populations of M.tbc - localised extracelullarly in cavitas, - intracelullarly in macrophages, - inside caseouse necrosis • Combination of 2-3 ATT. Resistence fighting -overgrowinf of resistent mutants in culture of M.tbc - for INH 1:105 for STM 1:106 in infectious place there is 107- 10 9 of bacteria

  27. ATB susceptibility • Susceptibility test for antituberculotics - ATT are dissolved in medium • Method of proportional susceptibility testing - dilution method. Dilution of inoculum so that there is from 100-300 CFU - colony forming units on a plate • If there is more than 1% of M. tbc cells resistent to ATT the therapy will not be cliniccňally suscessful

  28. Spontaneous appearance of resistent mycobacteria - without exposition to ATT • Frequency of resistent cells in the culture is 1:105 for INH and 1:106 for STM - if both are given in combination the incidence of resistent strains will be 1:1011. • The overall population of bacilli in patient with open cavity is 10 7 - 109 , so there is 102 - 104 resistent strains. • 1 ATT means overgrowing of resistent strains that will replace susceptible killed bacteria. • Combination of 2 and more ATT: INH+RIF - 9 months, + STR+ Ethanbutol for 2-8 weaks, from 2nd months only 2 times weakly, INH + Ethanbutol 18-24 months,

  29. Tests for ATT susceptibility - correlation between in vitro and therapy success. • If more than 1% of M. tbc in vitro are resistent - therapy will not be successful • Tests determine ratio between susceptible and resistent strains • Agar dilution method - depend on innoculum - if too thick - there is too much of resistent strains - false resistent, if less concentrated - false positive - possible resistent strains not identified. • Optimal dilution 100-300 CFU on plate • Inconvenience - aga can inhibit activity of ATT as well as of mycobacteria, long incubation decrease activity of ATT

  30. Principles of therapy • Therapy: ATT are active only on growing mycobacteria, growth depends on oxygen availability and pH (optimu neutral or alkaline) - Max in open cavity, min in caseouse necrose. • In i.c. - in phagosomes - pH is 5,5, acid - slow growth, less of bacilli, less resistent strains - ATT supporting acid environment - Pyrazinamide. (STM not able to enter phagosomes and looses activity in acid pH) • in chronic closed caseouse necrose - slow blood supply and oxygen, slow metabolism, less living cells, pH neutral but slow multiplication

  31. ATT • Bactericidal: STM - mycobacteria extracelullarly in cavities • INH - kills slowly and quickly growing cells • Rifampicin - effective on mycob. Closed in caseouse necrosis and macrophages • Pyrazinamide - only in acid pH and in macrophages • Bacteristatic: Ethanbutol - only in combination, able to penetrate in mycobacteria situated i.c. and e.c. • Capreomycin, Kanamycin - bactericidal, for e.c mycobacteria in cavities • Ethionamid, cycloserin - bacteriostatic for i.c and e.c

More Related